https://doi.org/10.30702/Ophthalmology30092020-11.1.1615-22

Zborovskaya A. V., Dorokhova A. E., Kolesnichenko V. V.

The Filatov Institute of Eye Diseases and Tissue Therapy of The National Academy of Medical Sciences of Ukraine, Odesa, Ukraine

Increasing the Efficiency of Treatment of Dry Eye Syndrome in Patients with Sjogren’s Syndrome by Application of the Preparation of Preserved Drops Containing Sodium Hyaluronate 0.4%

Abstract

Purpose. To increase the effectiveness of the treatment of dry eye syndrome in patients with Sjogren’s syndrome by using the drug without preservative drops containing sodium hyaluronate 0.4%.

Materials and methods. The research was carried out on the basis of “The Filatov Institute of Eye Diseases and Tissue Therapy of The National Academy of Medical Sciences of Ukraine”. The study included 14 patients aged 34 to 59 years (28 eyes) with dry eye syndrome concomitant with Sjogren’s syndrome. The examination of patients included: assessment of complaints, visometry, refractometry, culture tank from the conjunctiva, biomicroscopy, ophthalmoscopy, Schirmer’s test and Norn’s test, assessment of the “comfort of using drops” according to the questionnaire developed for this study.

Results. Before the appointment of instillations, Norn’s test was 6.5 seconds (SD 1.56) with a minimum of 3 seconds and a maximum of 9 seconds, a median of 6.5 seconds. After a month of treatment while taking drops, Norn’s test in the first group averaged 14.86 (SD 1.07) versus 13.86 (SD 1.07), but the difference was not statistically significant (p=1.0). The average number of instillations required per day for the first group was 4.14 (SD 1.06) and for the second group it was: 5.29 (SD 1.11).

Conclusion. Instillations of non-preservative drops containing sodium hyaluronate 0.4% (in a bottle equipped with an innovative reusable push-type ophthalmic dispenser (OSD) in the treatment of dry eye syndrome in patients with Sjogren’s syndrome are quite effective and very convenient to use.

Keywords: Sjogren’s syndrome, hyaluric acid, artificial tear, Schirmer’s test, Norn’s test, dry eye syndrome, tear film.

REFERENCES

1. Vasilyev VI. [Clinical picture, diagnosis and differential diagnosis of Sjogren’s disease]. RMJ. 2008;16(10):638-48. Russian.
2. Polunin GS, Kurenkov VV, Safonova TN, Polunina EG. [New clinical classification of dry eye syndrome]. Refractive surgery and ophthalmology. 2003;3(3):53-6. Russian.
3. Mirzakulova UR, Urazalin ZhB, Ibragimova RS, Aktasov NB, Ospanov MZh. [Diagnosis of Sjogren’s syndrome]. Vestnik KazNMU. 2014;5:225-7. Russian.
4. Maychuk YuF, Yani EV. [Choice of pharmacotherapy for various clinical forms of dry eye disease]. Ophthalmology in Russia. 2012;9(4):58-64. Russian. https://doi.org/10.18008/1816- 5095-2012-4-58-64
5. Vasilyev VI, Probatova NA, Varlamova YY, Tupitsyn NN, Simonova MV, Safonova TN, et al. [Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren’s disease]. Terapevticheskii arkhiv. 2004;79(8):61-7. Russian.
6. Fox R, Stern M, Michelson P. Update in Sjögren syndrome. Current opinion in rheumatology. 2000;12(5):391-8. https://doi.org/10.1097/00002281-200009000-00007
7. Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X. Treatment of primary Sjögren syndrome: a systematic review. JAMA. 2010;304(4):452-60. https://doi.org/10.1001/jama.2010.1014
8. Yamamura T et al., inventor; PHARMACEUTICAL CO., LTD. (JP), assignee. [A thermosensitive gelling artificial tear]. Russian patent RU 2710366. 2019.
9. Egorov AE, Eliseeva TO. [Hyaluronic acid as a component of tear substitutes]. RMJ. Clinical ophthalmology. 2016;4:224-6. Russian.
10. Egorov EA, Romanova TB. [Influence of the components of tear substitutes on efficacy and tolerance of the treatment in patients with dry eyesyndrome]. RMJ. Clinical ophthalmology. 2016;3:151-4. Russian.
11. Hamano T, Horimoto K, Lee M, Komemushi S. Sodium hyaluronate eyedrops enhance tear film stability. Jap. J. Ophthalmol. 1996;40(1):62-5.
12. Bron A. Duke-Elder Lecture. Prospects for the dry eye. Trans Ophthalmol Soc. 1985; 104:801-26.
13. Tiffany JM. Viscoelastic properties of human tears and polymer solutions. Adv. Exp. Med. Bio. 1994;350:267-70. https://doi.org/10.1007/978-1-4615-2417-5_45

Received: 2020 Aug 18
Published: October 2020